Recovery rate of rat skin micropores made by dissolving microneedles

Journal of Drug Delivery Science and Technology

Volumn 23, Issue 6, 2013, Pages 577-581

  Ito, Y ^a   Hamazaki, N ^a   Higashino, H ^a   Miyamoto, N ^a   Murakami, Y ^a   Inoue, N ^b   Takada, K ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b BioSerenTach Inc   (Japan)

Author keywords

Dissolving microneedles (DMs); Healing time; Rat; Skin; Transdermal delivery

Indexed keywords

CHONDROITIN SULFATE; EVANS BLUE; LACTATE DEHYDROGENASE;

ADSORPTION KINETICS; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARRAY CHIP; ARTICLE; BIOCHIP; CHEMICAL ANALYSIS; CONTROLLED STUDY; DISSOLVING MICRONEEDLE; ENZYME ACTIVITY; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; MALE; MICRONEEDLE; NONHUMAN; RAT; SKIN; SKIN DEFECT; SKIN MICROPORE; TISSUE ADHESION; WOUND HEALING;

EID: 84889585670     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(13)50087-6     Document Type: Article

References (34)

1. Pammolli F., Magazzini L., Riccaboni M. - The productivity crisis in pharmaceutical R&D. - Nature, 10, 428-439, 2011.
2. Amidon G.L., Lennernas H., Shah V.P., Crison J.R. - A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. - Pharm. Res., 12, 413-420, 1994.
3. Birchall J.C. - Stratum corneum bypassed or removed. - In: Enhancement in Drug Delivery, E. Touitou, B.W. Barry Eds., CRC Press, New York, 2007, p. 337-351.
4. Kim Y.C., Park J.H., Prausnitz M.R. - Microneedles for drug and vaccine delivery. -Adv. Drug Deliv. Rev., 64, 1547-68, 2012.
5. Park J., Allen M. G., Prausnitz M.R. Polymer - Microneedles for controlled-release drug delivery. - Pharm. Res., 23, 1008-1019, 2006. (Pubitemid 43781409)
6. Barry B., Williams A. - Penetration enhancers. - Adv. Drug. Deliv. Rev., 56, 603-618, 2004.
7. Cevc G. - Lipid vesicles and other colloids as drug carriers on the skin. - Adv. Drug. Deliv. Rev., 56, 675-711, 2004. (Pubitemid 38326939)
8. Preat V., Vanbever R. - Skin electroporation for transdermal and topical delivery. - Adv. Drug. Deliv. Rev., 56, 659-674, 2004. (Pubitemid 38326938)
9. Doukas A. - Transdermal delivery with a pressure wave. - Adv. Drug. Deliv. Rev., 56, 559-579, 2004.
10. Mitragotri S., Kost J. - Low-frequency sonophoresis: a review. - Adv. Drug. Deliv. Rev., 56, 589-601, 2004.
11. Prausnitz M.R., Mitragotri S., Langer R. - Current status and future potential of transdermal drug delivery. - Nat. Rev. Drug Discov., 3, 115-24, 2004. (Pubitemid 38239773)
12. Teo M.A.L., Shearwood C., Ng K.C., Lu J., Moochhala S. - In vitro and in vivo characterization of MEMS microneedles. - Biomed. Microdevices, 7, 47-52, 2005. (Pubitemid 40613130)
13. Matriano J.A., Cormier M., Johnson J., Young W.A., Buttery M., Nyam K., Daddona P.E. - Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. - Pharm. Res., 19, 63-70, 2002. (Pubitemid 34075108)
14. Henry S.D., McAllis V., Prausnitz M.G. - Microfabricated microneedles: A novel approach to transdermal drug delivery. - J. Pharm. Sci., 87, 922-925, 1998.
15. Takada K. - Microfabrication derived DDS: from batch to individual production. - Drug Discov. Then, 2, 140-155, 2008.
16. Cosman F., Lane N.E., Bolognese M., Zanchetta J., Garcia-Hernandez P.A., Sees K., Matriano J.A., Gaumer K., Daddona P.E. - Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women -. J. Clin. Endocrin. Metab., 95, 151-158, 2010.
17. Morawski M., Alpár A. Brückner G., Fiedler A., Jäger C., Gati G., Stieler J.T., Arendt T. - Chondroitin sulfate proteoglycan-based extracellular matrix in chicken (Gallus domesticus) brain. - Brain Res., 1275, 10-23, 2009.
18. Faissner A., Clement A., Lochter A., Streit A., Mandl C., Schachner M. - Isolation of a neural chondmitin sulfate proteoglycan with neurite outgrowth promoting properties. - J. Cell. Biol., 126, 783-799, 1994. (Pubitemid 24241390)
19. Umehara Y., Yamada S., Nishimura S., Shioi J., Robakis N.K., Sugahara K. - Chondroitin sulfate of appican, the proteoglycan form of amyloid precursor protein, produced by C6 glioma cells interacts with heparin-binding neuroregulatory factors. - FEBS Lett., 557, 233-238, 2004. (Pubitemid 38115901)
20. Wilson T.M., Snow D.M. - Chondroitin sulfate proteoglycan expression pattern in hippocampal development: potential regulation of axon tract formation. - J. Comp. Neurol., 424, 532-546, 2000.
21. Sintov A., Di-Capua N., Rubinstein A. - Cross-linked chondroitin sulfate: characterization for drug delivery purposes. - Biomaterials., 16, 473-478,1995.
22. Tsai F.M., Chiang L.Y., Wang F.L., Huang W.G., Wu C.P. - Oral sustained delivery of diclofenac sodium using calcium chondroitin sulfate matrix. - J. Biomater. Sci. Polym. Ed., 16, 1319-1331, 2005.
23. Ito Y., Nakahigashi T., Yoshimoto N., Ueda Yu., Hamasaki N., Takada K. - Transdermal insulin application system with dissolving microneedles. - Diabetes. Technol. Ther., 14, 891-899, 2012.
24. Fukushima K., Ise A., Morita H., Hasegawa R., Ito Y., Sugioka N., Takada K. - Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats. - Pharm. Res., 28, 7-21, 2011.
25. Ito Y., Hasegawa R., Fukushima K., Sugioka N., Takada K. - Self-dissolving microarray chip as percutaneous delivery system of protein drug. - Biol. Pharm. Bull., 33, 683-690, 2010.
26. Ito Y., Saeki A., Shiroyama K., Sugioka N., Takada K. - Percutaneous absorption of interferon-a by self-dissolving micropiles. - J. Drug. Target., 16, 243-249, 2008.
27. Augustin C., Collombel C., Damour O. - Use of dermal equivalent and skin equivalent models for in vitro cutaneous irritation testing of cosmetic products: comparison with in vivo human data. - Cutan. Ocul. Toxicol., 17, 5-17, 1998. (Pubitemid 28191466)
28. Ponec M., Kempenaar J. - Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants - Skin Pharmacol., 8, 49-59, 1995.
29. Van de Sandt J.J.M., Maas W.J.M., Doornink P.C., Rutten A. A.J.J.L. - Release of arachidonic and linoleic acid metabolites in skin organ cultures as characteristics of in vitro skin irritancy. - Fundam. Appl. Toxicol., 25, 20-28, 1995.
30. Koschier F.J., Roth R.N., Stephens T.J., Spence E.T., Duke M.A. - In vitro skin irritation testing of petroleum-based compounds in reconstituted human skin models. - Cutan. Ocul. Toxicol., 13, 23-37, 1994.
31. Gupta J., Gill H.S., Andrews S.N., Prausnitz M.R. - Kinetics of skin resealing after insertion of microneedles in human subjects. - J. Cont. Rel., 154, 148-155, 2011.
32. Dedrick R.L., Bischoff K.B., Zaharko D.S. - Inter-species correction of plasma concentration history of methotrexate. - Cancer. Chemother. Rep., 54, 95-102, 1970.
33. Matsuo A., Yokota Y., Zhai Y., Quan Y., Kamiyama F., Mukai Y., Okada N., Nakagawa S. - A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens. - J. Con. Rel., 161, 10-17, 2012.
34. Ito Y., Hamazaki N., Takada K. - Method to increase the systemically delivered amount of drug from dissolving microneedles. - Chem. Pharm. Bull., 61, 8-15, 2013.